Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 May 7;5(6):755-757.
doi: 10.1016/j.jacasi.2025.03.007. Online ahead of print.

Regional Heterogeneity in the Risk of Thrombosis and Bleeding in Patients With Peripheral Artery Disease

Shinya Goto  1 , Daisuke Yamasawa  2 , Shinichi Goto  3
Affiliations
Editorial

Regional Heterogeneity in the Risk of Thrombosis and Bleeding in Patients With Peripheral Artery Disease

Shinya Goto et al. JACC Asia. .
No abstract available

Keywords: guidelines; peripheral arterial disease; risk stratification.

PubMed Disclaimer

Conflict of interest statement

Financial Support and Author Disclosures The authors have received funding support from the Strategic Program for Innovational Research Field 1 for Super-computational Life Science, MEXT/JSPS KAKENHI Grant-in-Aid (Grant Number 19H03661), AMED (Grant Numbers A368TS and A447TR), the Fukuda Memorial Foundation, a grant from the Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering, Suzuken Memorial Foundation, and the Cross-ministerial Strategic Innovation Promotion Program (SIP) on “Integrated Health Care System” (grant number JPJ012425). Dr Goto has received a modest amount of personal fee from Amgen, Merck Sharp and Dohme, Jansen Pharma, and Antos therapeutics; and has received a quality fee from the American Heart Association as an Associate Editor for Circulation, Duke University, and Harvard University as a Steering Committee Member for Clinical Trials. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Thrombotic and Bleeding Events in the Japanese Registry of Peripheral Artery Disease Thrombotic and bleeding events in the Japanese registry within 726 days of observation are shown in each category of patients. The category is based on the thrombotic risk +/− and bleeding risk +/− according to European Society of Cardiology guideline 2024.
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.jacasi.2025.01.018

Similar articles

See all similar articles

References

    1. Levine G.N., Jeong Y-h, Goto S., et al. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol. 2014;11:597. - PubMed
    1. Torii S., Chiang C.-E., Hong S.J., et al. Asian perspective on the recently published practice guideline for acute coronary syndrome by ESC. Eur Heart J Acute Cardiovasc Care. 2024;13(1):162–164. - PubMed
    1. Goto S., Goto S. Oxford University Press US; 2022. Potent Antithrombotic Treatments in Asian vs. Non-Asian Patients; pp. 3553–3555. - PubMed
    1. van Asch C.J., Luitse M.J., Rinkel G.J., van der Tweel I., Algra A., Klijn C.J. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–176. - PubMed
    1. Goto S., Zhu J., Liu L., et al. Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. Am Heart J. 2014;168:303–309. - PubMed

Publication types

LinkOut - more resources